Timothy Hatlen to Biomarkers
This is a "connection" page, showing publications Timothy Hatlen has written about Biomarkers.
Connection Strength
0.293
-
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study. Lancet Microbe. 2024 06; 5(6):e559-e569.
Score: 0.194
-
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. J Infect Dis. 2025 Mar 17; 231(3):677-683.
Score: 0.051
-
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. J Infect Dis. 2024 03 14; 229(3):671-679.
Score: 0.048